Cite
MLA Citation
Anna Olsson-Brown et al.. “The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool.” Breast, vol. 44, 2019, pp. 94–100. http://access.bl.uk/ark:/81055/vdc_100078552351.0x00001e